August 2nd Highlights

  • New Zealand and adult-use cannabis - New Zealand could be the first country in the Asia Pacific to legalise the adult use of cannabis. Such a change may start a dominoes effect - Australia could follow suit. During such an uncertain period in history, perhaps adult-use cannabis would be good for the local economy? The state of Colorado sold more than $779 million in 2020 and paid more than $167 million in taxes and fees to the state. Data reference 
  • CBD and Epilepsy - A recent study showed 19% of patients were seizure-free at follow-up month 40 of using a cannabinoid preparation. Of the 37 patients, 27 reported >50% improvement, 2 patients reported <50% improvement and 1 patient discontinued therapy due to lack of efficacy. Weaning from concomitant antiepileptic drugs was obtained after 24 weeks from CBD introduction in 10 subjects. Researchers showed the efficacy of a CBD-based oil formulation with few significant side effects in patients with Treatment-resistant epilepsy of various etiologies. Study Reference

Canadian trial evaluates real-world use of medical cannabis products

Some WHO cannabis recommendations draw strong opposition at recent UN meeting

Hemp Concrete: from Roman bridges to a possible material of the future

Ecofibre snares US partner in Hemp Black textile push

NZ cannabis campaign on a knife edge

Australia’s Applied Cannabis Research and MedReleaf Australia launch an observational patient study

Coronavirus buy-local trend driving demand for Australian-grown medicinal cannabis

Analysis: an evolving industry battles political ambivalence and the GP knowledge gap

Experts: How to position for the next wave in cannabis